Role of Dronapushpi in Hyperlipidemia treatment.
Not Applicable
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2022/01/039284
- Lead Sponsor
- Dr Vivek Anand
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
obese patients.
obese patients with either NIDDM or hypertension.
But only those patients were included who had abnormal lipid profile.
Exclusion Criteria
Hypothyroidism.
Pregnant women.
Patients with IDDM.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method assessment of LDL,HDL,Trigyceride,total cholesterol through blood serum examination.Timepoint: AT duration of 15, 30,45 and 60 days.
- Secondary Outcome Measures
Name Time Method to study the change in level of LDL,Trigyceride,total cholesterol and increase in HDL through blood serum examination after trial drug administration.Timepoint: At 30,60 and 90 days